The CMO Leadership Awards

In cooperation with Life Science Leader, Nice Insight is pleased to announce the winners of the second
annual CMO Leadership Awards.

Nice Insight combines surveying of thousands of industry executives with other key analyses to
serve both partnering groups and facilitate better overall outsourcing collaborations. Life Science
Leader developed the annual CMO Leadership Awards to honor top performers based on responses
and better serve pharmaceutical and biopharmaceutical executives in their CMO vetting process.

R&D — Quality

Drug Life Cycle Stages: R&D, Formulated Drug Production
	AAIPharma Services "Our world-class scientific and technical teams are dedicated to delivering consistent, quality results with each project. Supported by integrated operations and project management, we collaborate directly with our clients to meet all analytical testing needs accurately and quickly.  AAIPharma’s exemplary audit and compliance track record reflect our commitment to developing the highest-quality formulations, dosage forms, and analytical results. Our clients recognize our desire to provide first-rate service across every service offering in our portfolio." Pat Walsh — Chief Executive Officer
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Almac Pharma Services "It is extremely encouraging that our customers regard Almac so highly in quality, innovation, productivity, regulatory, and reliability which is how we strive to be perceived through our core values and our overall aim of partnering to advance human health. Working with all the leaders in the pharmaceutical and biotech sectors our aim is to establish long-term partnerships and the fact that over 95% of our business is repeat is genuine evidence of our success." Alan Armstrong — CEO
Drug Life Cycle Stages: R&D, Drug Substance Production
	AmbioPharma, Inc. "AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered at our cGMP peptide manufacturing facility in North Augusta, SC. In our cGMP manufacturing facility in Shanghai, China, we manufacture peptides at very large scales, provide pilot manufacturing and process development, and manufacture raw materials, building blocks, and custom peptides." Chris Bai — President and CEO
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Aptuit "As a leading global pharmaceutical services company delivering early to mid phase drug development solutions, Aptuit is honored to be recognized for Quality across all dosage forms. By applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry our aim is to help customers realize their goals as efficiently, expeditiously and economically as possible … always at the highest level of quality." Chris Bland PhD — Site Director, Aptuit (Glasgow) Ltd.
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Boehringer Ingelheim "We are a leading biopharma contract manufacturer with 35 years of experience and an outstanding track record of 19 products brought to market. As an independent family-owned company, we see the contract manufacturing business as strategic priority which we underline with our new marketing brand Boehringer Ingelheim BioXcellence ™. Our "one-stop-shop" concept from DNA to fill & finish makes outsourcing easy and provides tailor-made service solutions according to our customer’s needs. With our global key account management team we are close to our customers and continue to put our customers first." Simon Sturge — Corporate Senior Vice President Biopharmaceutical
Drug Life Cycle Stages: R&D, Drug Substance Production
	CMC Biologics "CMC Biologics continually innovates to advance biopharmaceutical manufacturing to the next level. Our expertise in cGMP process development and manufacturing puts our clients’ projects in an optimal position to succeed. The recent MHRA approval demonstrates our continued commitment toward compliance and high-quality systems, which is the foundation of our customers’ clinical and commercial success. CMC Biologics is the industry leader among CMO’s in reliability, technical excellence, and quality. Right. On Time." Claes Glassell — Chief Executive Officer
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Cook Pharmica "There are many reasons why biopharmaceutical companies count on us to produce a consistently dependable product. First, we have a manufacturing facility with the right capabilities, equipment, and location, and a team of collaborative, experienced subject-matter experts. We have also put in place a flexible infrastructure with processes that allow for client customization and have strived as an organization to learn from our mistakes, becoming better listeners throughout the process." Cory Lewis — Vice President of Business Development & Marketing
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	GlaxoSmithKline "GSK is very pleased to receive this award and the recognition it brings to our efforts to be a pharmaceutical company that offers a trustworthy and dependable manufacturing service. We are invested in our partnership approach, listening to our customers and understanding their business requirements. GSK knows how important it is to continually deliver value in the eyes of the customer, and we look forward to building upon this success." Kristof Szent-Ivanyi — Business Development Director
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Irvine Scientific "Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is dedicated to delivering high quality, flexible, and on-time cGMP aseptic fill-finish and CMC development services to the pharmaceutical, biopharmaceutical, and medical device industries. We have a 25 year history understanding the importance of exceeding client expectations and we are committed to continuously enhancing and streamlining our services to provide clients with scientific solutions in an efficient manner." Dr. Assad J. Kazeminy — President, Founder, and CEO
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Lyophilization Technology, Inc. "Lyophilization Technology is a group of experienced and knowledgeable scientists, technicians, and support staff focused on providing development, technical services and clinical supply manufacturing for lyophilized products. Closely collaborating with our clients, we see our mission as applying our capabilities and expertise to the challenges of developing new and innovative products. Thank you to all the survey respondents in bestowing LTI with the CMO Leadership Awards for quality, reliability, and productivity." Edward H. Trappler — President
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Norwich Pharmaceuticals "At Norwich, we have dedicated ourselves to focus on our customers and the patients they serve. We understand that CMO Leadership Award recognition is directly tied to the success of our customers, and we are proud to be a reliable partner for all stages of the product lifecycle from product development to scale-up and commercial manufacturing through clinical services. Patients put trust into our customer’s products, and Norwich’s 125-year history of quality and compliance provides a foundation for that trust." Terry Novak — President
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Novasep "The need for better and safer products, particularly in life science industries, commands ever purer and more complex molecules. Novasep’s unique offering, which include contract manufacturing services and the supply of purification technologies, enables us to develop and implement cost-effective and sustainable solutions for the production of synthetic and biomolecules at the required purity. Furthermore, I believe that our commitment to the projects of our customers is key in building fruitful and durable relationships with them." Roger-Marc Nicoud — CEO
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Patheon "Patheon strives to exceed customer’s expectations. Innovative technical and scientific solutions, high quality and commitment to excellence is at the foundation of our work. It is gratifying to know that we have been recognized for this award. For customers to acknowledge our industry leadership in quality, innovation, productivity, regulatory and reliability is especially important, as these are the metrics we judge ourselves by and strive to perfect every day. Congratulations to Patheon’s global workforce. It’s their hard work that made this award possible." Jim Mullen — Chief Executive Officer
Drug Life Cycle Stages: R&D, Drug Substance Production
	Roche Custom Biotech "I am pleased to see Custom Biotech being recognized within the top five once again. Being part of the Roche organization allows us to provide expertise as well as state-of-the-art equipment and technologies from across all Roche business units to address our customer’s needs. Our goal is to enable the healthcare industry by providing state of the art, customized solutions and services for development and manufacturing of diagnostic and therapeutic products." Peter Schramm — Vice President
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Therapure Biopharma "Once again, we are privileged to receive the CMO Leadership award and honoured to be recognized by biopharma executives surveyed by Nice Insight as a leader in all categories (quality, reliability, innovation, productivity, and regulatory). I would like to take this opportunity to thank all the employees of Therapure, whose daily contributions and diligence is the driving force behind our company’s success as well as our clients, without whom this would not have been possible." Nick Green — CEO
Drug Life Cycle Stages: R&D, Formulated Drug Production
	UPM Pharmaceuticals "UPM Pharmaceuticals focuses on meeting challenging timelines for development work, provision of clinical supplies, and associated lab services. UPM maintains a lean and flat corporate structure. This allows production decisions and quality oversight on every project to be made and driven daily with input from every department and overseen at the highest levels of our operations. We pride ourselves on providing constant communication with our clients. UPM clearly understands winning and keeping business in this highly competitive industry is about producing results for our clients." Jim Gregory — President and COO
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Vetter Pharma International GmbH "We never lose sight that the products we manufacture for our clients are used by patients they serve. For more than 25 years, Vetter provides high-quality aseptic fill and finish with reliable delivery. We appreciate recognition of our dedication to our customers with this award." Peter Soelkner — Vetter Managing Director
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Wuxi AppTec "We are honored to be consistently recognized as a top outsourcing company in China. This speaks volume for WuXi's service business model. As a leading life science R&D service company, we will strive to improve our capabilities and capacities to better serve our pharmaceutical, biotechnology, and medical device customers and partners, to help bring new products into market sooner and more cost effectively to benefit patients in needs." Suhan Tang, Ph.D — Chief Manufacturing Officer